Skip to main content

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

Drug Recall

Official source record

Recall number
D-1876-2019
Event ID
83731
Classification
Class II
Status
Terminated
Recalling company
Cardinal Health dba Specialty Pharmaceutical Services
Reason for recall
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Report date
October 2, 2019
Recall initiation date
September 6, 2019
Termination date
October 8, 2020
Distribution pattern
Nationwide in the U.S.

Drug product identifiers

Manufacturer
GlaxoSmithKline LLC
Brand name
NUCALA
Generic name
MEPOLIZUMAB
Substance name
MEPOLIZUMAB
Product NDCs
0173-0881; 0173-0892; 0173-0904
Package NDCs
0173-0881-01; 0173-0881-61; 0173-0892-01; 0173-0892-42; 0173-0892-61; 0173-0892-63; 0173-0904-42
Route
SUBCUTANEOUS

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.